Search Results - "Prevoo, W."

Refine Results
  1. 1
  2. 2

    Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma by Aarts, B. M., Prevoo, W., Meier, M. A. J., Bex, A., Beets-Tan, R. G. H., Klompenhouwer, E. G., Gómez, F. M.

    “…Objectives To assess the safety and efficacy of percutaneous microwave ablation (MWA) of histologically proven T1 renal cell carcinoma (RCC). Methods We…”
    Get full text
    Journal Article
  3. 3

    Prospective experimental treatment of colorectal cancer patients based on organoid drug responses by Ooft, S.N., Weeber, F., Schipper, L., Dijkstra, K.K., McLean, C.M., Kaing, S., van de Haar, J., Prevoo, W., van Werkhoven, E., Snaebjornsson, P., Hoes, L.R., Chalabi, M., van der Velden, D., van Leerdam, M., Boot, H., Grootscholten, C., Huitema, A.D.R., Bloemendal, H.J., Cuppen, E., Voest, E.E.

    Published in ESMO open (01-06-2021)
    “…Organoid technology has recently emerged as a powerful tool to assess drug sensitivity of individual patient tumors in vitro. Organoids may therefore represent…”
    Get full text
    Journal Article
  4. 4

    Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy by Tanis, E, Spliethoff, J.W, Evers, D.J, Langhout, G.C, Snaebjornsson, P, Prevoo, W, Hendriks, B.H.W, Ruers, T.J.M

    Published in European journal of surgical oncology (01-02-2016)
    “…Abstract Background The success of radiofrequency (RF) ablation is limited by the inability to assess thermal tissue damage achieved during or immediately…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients by Bex, A., Vermeeren, L., Meinhardt, W., Prevoo, W., Horenblas, S., Valdés Olmos, R. A.

    Published in World journal of urology (01-12-2011)
    “…Purpose To apply single-photon emission computed tomography (SPECT) in combination with computed tomography (CT) for preoperative identification of sentinel…”
    Get full text
    Journal Article
  7. 7

    Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin by Hompes, D, Prevoo, W, Ruers, T

    Published in Cancer imaging (24-03-2011)
    “…At diagnosis 10-25% of patients with colorectal liver metastases (CRLM) present as resectable disease. Liver resection is the gold standard treatment,…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer by Hompes, D., Aalbers, A., Boot, H., van Velthuysen, M.-L., Vogel, W., Prevoo, W., van Tinteren, H., Verwaal, V.

    Published in Colorectal disease (01-08-2014)
    “…Aim Twelve to 13% of patients with colorectal cancer (CRC) develop peritoneal carcinomatosis (PC), the majority of whom present with unresectable disease. This…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors by Jansen, M.C, van Wanrooy, S, van Hillegersberg, R, Rijken, A.M, van Coevorden, F, Prevoo, W, van Gulik, T.M

    Published in European journal of surgical oncology (01-06-2008)
    “…Abstract Introduction Local therapies for liver tumors are considered to be safe. However, cryoablation (CA) has been associated with an exaggerated systemic…”
    Get full text
    Journal Article
  14. 14

    Adverse effects of radiofrequency ablation of liver tumours in the Netherlands by Jansen, M. C., van Duijnhoven, F. H., van Hillegersberg, R., Rijken, A., van Coevorden, F., van der Sijp, J., Prevoo, W., van Gulik, T. M.

    Published in British journal of surgery (01-10-2005)
    “…Background: Radiofrequency ablation (RFA) is a new treatment for liver tumours. Complications encountered after RFA in the Netherlands were evaluated in the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers by Kaas, R, Kroger, R, Hendriks, J H C L, Besnard, A P E, Koops, W, Pameijer, F A, Prevoo, W, Loo, C E, Muller, S H

    Published in European radiology (01-09-2004)
    “…Breast cancers in gene mutation carriers may escape mammographic detection because of rapid growth and tumor expansion. Therefore, they may mimic benign…”
    Get full text
    Journal Article
  17. 17

    Technical considerations in laparoscopic liver surgery : A solid organ easily forgotten? by BERENDS, F. J, MEIJER, S, PREVOO, W, BONJER, H. J, CUESTA, M. A

    Published in Surgical endoscopy (01-08-2001)
    “…Laparoscopic solid organ surgery has gained growing acceptance, but this does not hold for laparoscopic surgery of the liver. Laparoscopic liver surgery mainly…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands by Mutsaerts, E.L.A.R, Van Coevorden, F, Krause, R, Borel Rinkes, I.H.M, Strobbe, L.J.A, Prevoo, W, Tollenaar, R.A.E.M, Van Gulik, T.M

    Published in European journal of surgical oncology (01-11-2003)
    “…Aims: The aim of this study is to report initial experience with radiofrequency thermoablation (RFA) of malignant hepatic tumours. Methods: From June 1999 to…”
    Get full text
    Journal Article